Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Commercial Progress Update

16 Oct 2012 07:00

RNS Number : 7480O
Phorm Corporation Limited
16 October 2012
 



 

16 October 2012

 

Phorm Corporation Limited ("Phorm" or the "Company")

 

Commercial Progress Update - Initial text advertising results

 

Phorm (AIM: PHRM), the internet personalisation technology company, is pleased to announce a further update on the operational progress of its commercial deployment in Turkey. Following the start of commercial activities in July, the Company announced on 20 September that it had made significant traction with all three key commercial elements - Users, Publishers and Advertisers. Today we are pleased to announce the initial results of our text advertising product.

 

Having begun commercial operations in the display advertising space by demonstrating how it could lift the performance of advertising by a factor of at least three, the Company has now demonstrated that it can use ISP data to profitably show targeted text advertising without the involvement of a search engine.

 

Text advertising accounts for more than half of the global advertising market and is dominated by search since search has been the primary method of associating someone with a keyword level interest. Although there are ways of showing text advertising on third party websites, results have been mixed at best since the content of any one website is not always a strong indicator of a consumer's interest. Phorm, together with its ISP partners, is uniquely positioned to identify repeated, keyword level behaviour and bring revenue from targeted text advertising within reach of most pages on the internet by showing a different text advertisement to each person visiting that web page based up on repeated keyword level interest prior to visiting that site.

 

The Company tested its text advertising system on more than twenty million advertising impressions, a statistically meaningful sample, across a wide variety of websites and advertisers. Over 20 campaigns were run in sectors such as electronics, travel, fashion, mobile phones, banking and jobs. Based on the results, we were able to conclude that the model was valid with clicks being generated at margins in excess of 80%.

 

The Company believes that, as it continues to deploy across Turkish ISP users and websites and builds scale over the coming weeks, it will be able to diversify the range of options available to text advertisers in the online advertising market which would represent a significant revenue opportunity to the broader ecosystem of websites in Turkey and markets in which Phorm is deployed. The initial results also identified opportunities to improve both the performance and the process of its text advertising solution, which are currently being implemented. The Company looks forward to growing revenues significantly as commercial operations expand in Turkey based on these excellent initial results.

 

Kent Ertugrul, CEO of Phorm, commented, "This is truly a major milestone in the development of the business. Text advertising represents over half of the $90bn global advertising market and today, for the first time, we have demonstrated that there is a viable alternative delivery model based on our partnership with ISPs. We are very excited about the prospects of our business in Turkey and are now focused on using the excellent initial results to build revenue aggressively."

 

 

 

 

For Enquiries

Phorm, Inc.

Mark Williams (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

 

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

 

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

 

Hudson Sandler +44 20 7796 4133

Charlie Jack

Charlie Barker

 

- ends -

 

 

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

Phorm, under the predecessor holding company of the group Phorm Inc., was admitted to the AIM market of the London Stock Exchange in 2007 and has over 140 employees and contractors.

 

For more information, please visit: www.phorm.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFMEEIFESESS
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.